⌘K

Home/Filings/4/0001078782-16-003481

4//SEC Filing

VOLITIONRX LTD 4

Accession 0001078782-16-003481

$VNRXCIK 0000093314operating

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 4:27 PM ET

Size

5.4 KB

Accession

0001078782-16-003481

Insider Transaction Report

Form 4

Period: 2016-09-13

VOLITIONRX LTDVNRX

KRATOCHVIL DAVID MATTHEW

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2016-09-13+25,000→ 25,000 total
Exercise: $4.65From: 2017-09-13Exp: 2022-09-13→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]A total of 25,000 Options were granted on September 13, 2016 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

VOLITIONRX LTD

CIK 0000093314

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000093314

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 4:27 PM ET
Size: 5.4 KB

View on SEC.gov